Bryan King, MD
Professor of Psychiatry and Behavioral Sciences
University of Washington
Dr. King is Professor of Psychiatry and Behavioral Sciences at the University of Washington and Co-Chair of the Autism and Intellectual Disability Committee of the American Academy of Child and Adolescent Psychiatry. He was also a member of the DSM-5 workgroup responsible for neurodevelopmental disorders.
Dr. King has been focused on psychiatric aspects of neurodevelopmental disorders, and upon the pathogenesis and treatment of severe behavioral disturbance in autism, in particular. He has participated in several clinical trials of therapeutics in autism at all stages of development, and has been continuously funded by the National Institutes of Health to do this and related work as a Principal Investigator since 1990.
Dr. King chaired the multi-site clinical trial funded by the NIH, STAART (studies to advance autism research and treatment) Centers, examining the potential role for citalopram in the treatment of children with autism who have significant problems with repetitive behaviors. His experience with clinical trials and the extraordinary clinical program at Seattle Children’s Hospital support his team's participation in several multi-site clinical trials in autism and they are partners in important networks including the HRSA sponsored AIR-B and NIH sponsored RUPP and FAST-AS networks.
Dr. King has received two lifetime achievement awards for his work, including the Frank Menolascino Award from the American Psychiatric Association and the George Tarjan Award from the American Academy of Child and Adolescent Psychiatry.
To contact GME, email us at [email protected]